Preclinical imaging is rapidly becoming a standard technology for drug discovery and development. This adoption has been driven by the increasing pressure on pharmaceutical companies to identify ways ...
This special collection on Artificial Intelligence in Preclinical Imaging is dedicated to exploring how AI is reshaping imaging in preclinical research across modalities and animal models. Preclinical ...
BIOEMTECH, a developer of high-resolution PET and SPECT imaging systems for preclinical and translational research, today ...
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today debuts its enhanced imaging portfolio designed to drive innovation across diverse applications in preclinical research with the launch ...
Revvity launched its Living Image™ Synergy AI multimodal analysis software for in vivo imaging researchers. The solution provides a unified platform with AI capabilities for seamless data analysis ...
Magnetic resonance imaging (MRI) is a well-reputed imaging modality for clinically managing patients who suffer from neurological disorders. It enables the discovery of macro- and microstructural ...
DUBLIN--(BUSINESS WIRE)--The "Pre-clinical Imaging Market Analysis by Imaging Products (Optical Imaging, CT Imaging, Multi-Modal Imaging, MRI Imaging, Ultrasound Imaging, Reagents, Services), and by ...
Revvity RVTY announced that it has launched three next-generation technologies that aim to help scientists drive breakthrough discoveries in biological research. These technologies include the IVIS ...
Bruker Corporation (Nasdaq: BRKR) today announced that it has acquired Spectral Instruments Imaging LLC, a leader in preclinical in-vivo optical imaging systems. This acquisition fills a gap in the ...
Analytical instrument vendor Bruker is set to further expand its offering of optics-based equipment with the acquisition of Arizona-based Spectral Instruments Imaging (SII). Established in Tucson’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results